Narkhede Vishal, Bolar Siddhant, Aggarwal Deepanshu, Ghorai Rudra Prasad, Kalra Sidhartha, Dorairajan Lalgudi Narayanan, Sreenivasan Sreerag Kodakkattil
Department of Urology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
Urol Ann. 2025 Jul-Sep;17(3):179-185. doi: 10.4103/ua.ua_98_24. Epub 2025 Jul 18.
Radical cystectomy (RC) is the standard treatment for muscle-invasive and high-risk nonmuscle-invasive bladder cancer. The impact of minimally invasive surgeries (MIS) such as laparoscopic and robot-assisted RC (RARC) on outcomes and morbidity remains debated, especially in India. This study compares perioperative outcomes and complications of open RC (ORC), laparoscopic RC (LRC), and RARC.
This prospective cohort study included 186 patients who underwent ORC, LRC, or RARC at our institution between October 2013 and April 2024. Preoperative parameters such as age, body mass index (BMI), comorbidities, and chemotherapy status were recorded. Postoperative parameters including operative time, blood loss, return of bowel function, complications, and survival rates were analyzed. Pathological parameters such as stages, lymph node yield, and positive surgical margins were assessed.
The study included 120 ORC, 56 RARC, and 10 LRC patients. The median age was highest in the laparoscopic group (67.4 ± 6.33 years) with a higher BMI (26.22 ± 5.24). Operative time was longest for RARC (414 ± 115.7 min) versus 357.96 ± 60.08 for ORC ( ≤ 0.0001), but blood loss was lowest (413.39 ± 165.55 ml) versus 518.33 ± 171.49 for ORC ( = 0.0001). Return of bowel function was fastest in the RARC group (4.27 + 2.79 days). Complications were highest in the ORC group (70.83%) compared to RARC (51.78%) ( = 0.03). Mean lymph node yield was highest in RARC (24.35 ± 3.06) versus Lap RC (22 ± 2.87) and ORC (19.47 ± 3.56) ( ≤ 0.0001). Overall survival rate was 78.57% for RARC compared to 74.16% for ORC.
Our findings suggest that while RARC provides advantages in blood loss, complication rates, and mean lymph node yield, its longer operative time necessitates further optimization. The study highlights the importance of considering patient-specific factors and regional contexts in surgical approach decisions, with RARC showing promising results.
根治性膀胱切除术(RC)是肌层浸润性和高危非肌层浸润性膀胱癌的标准治疗方法。腹腔镜和机器人辅助根治性膀胱切除术(RARC)等微创手术(MIS)对手术结果和发病率的影响仍存在争议,尤其是在印度。本研究比较了开放性根治性膀胱切除术(ORC)、腹腔镜根治性膀胱切除术(LRC)和机器人辅助根治性膀胱切除术(RARC)的围手术期结果和并发症。
这项前瞻性队列研究纳入了2013年10月至2024年4月期间在我们机构接受ORC、LRC或RARC手术的186例患者。记录术前参数,如年龄、体重指数(BMI)、合并症和化疗状态。分析术后参数,包括手术时间、失血量、肠功能恢复、并发症和生存率。评估病理参数,如分期、淋巴结获取数量和手术切缘阳性情况。
该研究包括120例接受ORC的患者、56例接受RARC的患者和10例接受LRC的患者。腹腔镜组的中位年龄最高(67.4±6.33岁),BMI也更高(26.22±5.24)。RARC的手术时间最长(414±115.7分钟),而ORC为357.96±60.08分钟(P≤0.0001),但失血量最低(413.39±165.55毫升),而ORC为518.33±171.49毫升(P = 0.0001)。RARC组的肠功能恢复最快(4.27 + 2.79天)。ORC组的并发症发生率最高(70.83%),而RARC组为51.78%(P = 0.03)。RARC的平均淋巴结获取数量最高(24.35±3.06),而腹腔镜根治性膀胱切除术(Lap RC)为22±2.87,ORC为19.47±3.56(P≤0.0001)。RARC的总生存率为78.57%,而ORC为74.16%。
我们的研究结果表明,虽然RARC在失血量、并发症发生率和平均淋巴结获取数量方面具有优势,但其较长的手术时间需要进一步优化。该研究强调了在手术方式决策中考虑患者特定因素和地区背景的重要性,RARC显示出了有前景的结果。